Sector: Pharmaceuticals & Biotechnology
|Small Cap
Samrat Pharmachem Share Price
Samrat Pharmachem Ltd.
₹207.05
-2.05(-0.98%)
5th Jun 2026 | 3:16 PM
NSE :
Open Free Demat Account
Samrat Pharmachem Performance
Price Movement
N/A
₹207.05
₹212.95
↘ Today's Low↗ Today's High
1 Year Performance
Data is not available
Markets Today
High₹212.95
Low₹207.05
Open at₹209.25
Prev Close₹209.10
Volumes1.99 K
Avg Price₹208.29
Lower Circuit₹165.75
Upper Circuit₹248.55
Historical Performance
3M High₹269.00
3M Low₹190.00
1 Yr High₹389.00
1 Yr Low₹190.00
3 Yr High₹646.00
3 Yr Low₹190.00
5 Yr High₹1,250.00
5 Yr Low₹170.00
Samrat Pharmachem Fundamentals
Market Cap
Low in industry
64 Cr.
PE Ratio (TTM)
Negative PE TTM
-19.30
Dividend Yield
Below industry Median
0.50
Net Profit TTM
147% decr over last year
-3.31
Net Profit Growth
147% decr over last year
-3.31
PEG Ratio
Below industry Median
0.10
ROE
149% decr over last year
-4.85
Operating Revenue TTM
289.72
Operating Revenue Growth
1.4% incr over last year
Book Value
Low in industry
0.90
MFI
MFI is mid-range
59.92
RSI
RSI is mid-range
44.83
EPS (TTM)
-
Debt to Equity
-
Face Value
-
Operating Profit Margin Qtr.
-
Operating Profit Qtr.
-
Net Profit Qtr.
-
Operating Revenue Qtr.
-
PB Ratio
0.90
Samrat Pharmachem Financials
*All values are in Rs. Cr
Loading chart...
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 71.77 | 63.43 | 78.87 | 75.65 | 71.20 |
| Operating Expense | 73.02 | 64.08 | 79.23 | 75.53 | 71.08 |
| Operating Profit | -1.24 | -0.66 | -0.36 | 0.12 | 0.13 |
| Depreciation | 0.19 | 0.19 | 0.18 | 0.17 | 0.16 |
| Interest | 0.14 | 0.13 | 0.26 | 0.44 | 0.22 |
| Tax | 0.16 | -0.11 | -0.16 | 0.44 | 0.04 |
| Net Profit | -2.04 | -0.46 | -0.59 | -0.23 | -0.40 |
Samrat Pharmachem Technicals
Samrat Pharmachem Ltd. EMA & SMA
₹207.05
-2.05 (-0.98%)
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
Day EMA5 ₹211.5
Day EMA10 ₹215.2
Day EMA12 ₹215.7
Day EMA20 ₹216.2
Day EMA26 ₹216
Day EMA50 ₹215.5
Day EMA100 ₹222.9
Day EMA200 ₹249.6
Samrat Pharmachem Support and Resistance
Resistance
First Resistance₹211.05
Second Resistance₹214.95
Third Resistance₹216.95
Support
First Support₹205.15
Second Support₹203.15
Third Support₹199.25
Technical Indicators
Day RSI44.83
Day MFI59.92
Day ADX20.29
Day Commodity Channel Index-69.30
William-92.31
Day MACD-0.22
Day MACD Signal Line1.78
Day ATR14.73
Day ROC125-15.55
Day ROC21-0.07
Samrat Pharmachem Shareholding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 49.1 | 49.1 | 49.1 | 49.1 | 49.1 | 49.1 |
| FII | 3.2 | 3.2 | 0 | 3.2 | 3.2 | 3.2 |
| DII | 0 | 0 | 3.2 | 0 | 0 | 0 |
| Public | 47.7 | 47.7 | 47.7 | 47.7 | 47.7 | 47.7 |
Samrat Pharmachem Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 2.08 K | 3.82 K | 54.54% |
| Week | 6.28 K | 11.79 K | 53.30% |
| 1 Month | 2.66 K | 4.4 K | 60.40% |
| 6 Month | 1.71 K | 2.36 K | 72.41% |
Samrat Pharmachem SWOT Analysis
Strengths5
Weakness9
Opportunity0
Threats0
Rising Net Cash Flow and Cash from Operating activity
PEG lower than Industry PEG
Companies with Low Debt
Companies with Zero Promoter Pledge
Stock with Low PE (PE < = 10)
Samrat Pharmachem Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 18 Sep, 2025 | 1 | FINAL | 18 Sep, 2025 | Equity Share |
| 19 Sep, 2024 | 1 | FINAL | 19 Sep, 2024 | Equity Share |
| 18 Sep, 2023 | 1 | FINAL | 18 Sep, 2023 | Equity Share |
| 22 Sep, 2022 | 1 | FINAL | Equity Share |
Samrat Pharmachem Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹44 | ₹550.55 | ₹216.05 | ₹268.50 | ₹41.43 | ₹6.36 |
| % Change | 2.42% | 0.29% | -1.84% | 0.00% | -1.99% | -1.09% |
| Revenue TTM (₹ Cr) | - | - | - | - | ₹1.27 | ₹83.60 |
| Net Profit TTM (₹ Cr) | - | - | - | - | ₹-0.25 | ₹-34.95 |
| PE TTM | 15.30 | - | 14.60 | 38.40 | -98.10 | -1.50 |
| 1 Year Return | 39.08 | 820.67 | 539 | |||
| ROCE | - | 3.56 | - | - | - | -5.63 |
Similar Stocks
APPL
Aptus Pharma Ltd.
₹ 229.65
+2.00%
AMANTA
Amanta Healthcare Ltd.
₹ 134.70
+1.84%
AHCL
Anlon Healthcare Ltd.
₹ 13.98
-1.06%
PATELCHEM
Patel Chem Specialities Ltd.
₹ 84.00
-2.33%
APL
Asston Pharmaceuticals Ltd.
₹ 70.00
-4.12%
VEERHEALTH
Veerhealth Care Ltd.
₹ 24.24
+1.04%
VIVOBIOT
Vivo Bio Tech Ltd.
₹ 24.48
+1.83%
GUFICBIO
Gufic BioSciences Ltd.
₹ 372.30
+5.07%
JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd.
₹ 202.01
-0.71%
GUJTHEM
Gujarat Themis Biosyn Ltd.
₹ 413.00
+0.33%
MAKERSL
Makers Laboratories Ltd.
₹ 145.60
-5.91%
UNICHEMLAB
Unichem Laboratories Ltd.
₹ 363.00
-2.55%
FERMENTA
Fermenta Biotech Ltd.
₹ 338.00
+5.77%
ANUHPHR
Anuh Pharma Ltd.
₹ 75.50
-0.47%
BLISSGVS
Bliss GVS Pharma Ltd.
₹ 436.05
-4.42%
PARNAXLAB
Parnax Lab Ltd.
₹ 127.65
-1.66%
NOVARTIND
Novartis India Ltd.
₹ 1392.75
+3.08%
MOREPENLAB
Morepen Laboratories Ltd.
₹ 43.94
-2.20%
LYKALABS
Lyka Labs Ltd.
₹ 63.05
+4.46%
AMBALALSA
Ambalal Sarabhai Enterprises Ltd.
₹ 34.00
-2.33%
AMRUTANJAN
Amrutanjan Health Care Ltd.
₹ 552.10
+1.72%
ASTONEALAB
Astonea Labs Ltd.
₹ 280.00
-0.71%
FAQ's on SAMRATPH
What is the Market Capitalization of Samrat Pharmachem Ltd.?
Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Samrat Pharmachem Ltd. is approximately ₹ 64 Cr.
What are the PE and PB ratios for Samrat Pharmachem Ltd.?
Based on recent data, the Price-to-Earnings (PE) ratio for Samrat Pharmachem Ltd. is -19.3, and the Price-to-Book (PB) ratio is 0.9.
What is the 52-Week High and Low for Samrat Pharmachem Ltd.?
Over the past 52 weeks, the highest price reached by Samrat Pharmachem Ltd. shares was ₹ 389, and the lowest price was ₹ 190.
What is the current dividend yield for Samrat Pharmachem Ltd.?
As of 6 June 2025, the dividend yield for Samrat Pharmachem Ltd. is 0.5%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.
Who are the major shareholders of Samrat Pharmachem Ltd.?
Significant shareholdings in Samrat Pharmachem Ltd. typically include entities such as:
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
- Promoter
- Public
- FII
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Samrat Pharmachem Ltd. in the Pharmaceuticals & Biotechnology sector?
In the Pharmaceuticals & Biotechnology sector, Samrat Pharmachem Ltd. is often compared with other major players such as
Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.
What is the latest dividend information for Samrat Pharmachem Ltd.?
Samrat Pharmachem Ltd. last declared a FINAL dividend of ₹ 1 per share for the financial period ending 2025. The record date was set as 2025-09-18, and the payment was/is scheduled around 2025-09-18. For the most current dividend announcements, refer to official company filings.
Invest Anytime, Anywhere
By signing up I certify terms, conditions & privacy policy